Radisens’ breakthrough innovation has been realised through seasoned R&D and commercial teams across the convergent fields of medical diagnostics, consumer electronics and centrifugal microfluidics. Our initial consumable panels integrate over eight multiplexed immunoassay and biochemistry assays each for the management of chronic care patients suffering from diabetes, hypertension and chronic kidney disease. Each panel requires only a finger-prick of patient’s blood, with clinical results within minutes. All assay and sample preparation steps are integrated on the consumable panel, ensuring true sample-to-answer solutions.
The Radisens Platform
The miniaturised point-of-care platform replaces the large, costly, cumbersome and high maintenance clinical diagnostic instruments used in today’s central pathology labs. This high performance battery operated platform combines multiple patent pending innovations at the convergence of medical diagnostics, consumer electronics and centrifugal microfluidics.
Platform Features
This disruptive diagnostics platform offers several advanced features, uniquely targeted to point-of-care, including:
- single integrated instrument integrating multiple immunoassay and biochemistry assays,
- initial assay panels for chronic disease monitoring/management of diabetes, hypertension and chronic kidney disease
- all assay and sample preparation steps integrated onto consumable
- supports new assay panel offerings via software menu updates,
- over five orders of dynamic range,
- integrated controls and calibration,
- solid state digital multi-colour optical detection,
- option to interface with third party middleware, data analytics and LIS software,
- advanced noise cancellation and analyte microanalysis algorithms.
Different assay panels may be performed using the same operator protocol – simply add unmetered whole blood using a fingerstick, load the disc into the instrument and run the assay.